Folic Acid Supplementation to Prevent Neural Tube Defects: US Preventive Services Task Force Reaffirmation Recommendation Statement
- PMID: 37526713
- DOI: 10.1001/jama.2023.12876
Folic Acid Supplementation to Prevent Neural Tube Defects: US Preventive Services Task Force Reaffirmation Recommendation Statement
Abstract
Importance: Neural tube defects are among the most common congenital malformations in the US, with an estimated 3000 pregnancies affected each year. Many of these neural tube defects are caused by low folate levels in the body.
Objective: The US Preventive Services Task Force (USPSTF) commissioned a reaffirmation evidence update on the benefits and harms of folic acid supplementation.
Population: Persons who are planning to or could become pregnant.
Evidence assessment: The USPSTF concludes that, for persons who are planning to or could become pregnant, there is high certainty that folic acid supplementation has a substantial net benefit to prevent neural tube defects in their offspring.
Recommendation: The USPSTF recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 μg) of folic acid. (A recommendation).
Summary for patients in
-
Folic Acid to Prevent Neural Tube Defects.JAMA. 2023 Aug 1;330(5):480. doi: 10.1001/jama.2023.14061. JAMA. 2023. PMID: 37526717
Similar articles
-
Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement.JAMA. 2017 Jan 10;317(2):183-189. doi: 10.1001/jama.2016.19438. JAMA. 2017. PMID: 28097362
-
Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2023 Aug 1;330(5):460-466. doi: 10.1001/jama.2023.9864. JAMA. 2023. PMID: 37526714
-
Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2009 May 5;150(9):626-31. doi: 10.7326/0003-4819-150-9-200905050-00009. Ann Intern Med. 2009. PMID: 19414842
-
Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force.Ann Intern Med. 2009 May 5;150(9):632-9. doi: 10.7326/0003-4819-150-9-200905050-00010. Ann Intern Med. 2009. PMID: 19414843 Review.
-
Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2017 Jan 10;317(2):190-203. doi: 10.1001/jama.2016.19193. JAMA. 2017. PMID: 28097361 Review.
Cited by
-
Insights and perceptions: Investigating pregnant women's attitudes, understanding, and factors influencing knowledge regarding medication usage during pregnancy-A cross-sectional study.PLoS One. 2024 Oct 1;19(10):e0311235. doi: 10.1371/journal.pone.0311235. eCollection 2024. PLoS One. 2024. PMID: 39352911 Free PMC article.
-
Supplementation with Folic Acid or 5-Methyltetrahydrofolate and Prevention of Neural Tube Defects: An Evidence-Based Narrative Review.Nutrients. 2024 Sep 18;16(18):3154. doi: 10.3390/nu16183154. Nutrients. 2024. PMID: 39339754 Free PMC article. Review.
-
Antenatally diagnosed myelomeningocele with associated chiari ii malformation in the third trimester. A case report.Radiol Case Rep. 2024 Sep 19;19(12):5990-5994. doi: 10.1016/j.radcr.2024.09.045. eCollection 2024 Dec. Radiol Case Rep. 2024. PMID: 39328952 Free PMC article.
-
The effect of folic acid intake on congenital anomalies. A systematic review and meta-analysis.Front Pediatr. 2024 Jul 19;12:1386846. doi: 10.3389/fped.2024.1386846. eCollection 2024. Front Pediatr. 2024. PMID: 39100647 Free PMC article.
-
Epigenetic regulation by TET1 in gene-environmental interactions influencing susceptibility to congenital malformations.bioRxiv [Preprint]. 2024 Jul 8:2024.02.21.581196. doi: 10.1101/2024.02.21.581196. bioRxiv. 2024. PMID: 39026762 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
